Author:
Namm Jukes P.,Mueller Jeffrey,Kocherginsky Masha,Kulkarni Swati
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Klauber-DeMore N, Tan LK, Liberman L, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol. 2000;7(9):636–42.
2. Silverstein MJ, Waisman JR, Gamagami P, et al. Intraductal carcinoma of the breast (208 cases). Clinical factors influencing treatment choice. Cancer. 1990;66(1):102–8.
3. Edge SB. American Joint Committee on Cancer: AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2009.
4. Werling RW, Hwang H, Yaziji H, et al. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain. Am J Surg Pathol. 2003;27(1):82–90.
5. Reis-Filho JS, Milanezi F, Amendoeira I, et al. p63 Staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast. J Clin Pathol. 2002;55(12):936–9.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献